Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1417 of 5804
-
New hope for chronic knee pain after replacement? radiofrequency ablation trial launches
Symptom relief Recruiting nowKnee osteoarthritis pain is one of the conditions commonly seen in general and specialized medicine. Knee arthroplasty is one of the most successful orthopedic surgeries for the treatment of this disease, significantly improving pain, disability, and the overall quality of life f…
Phase: NA • Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New hope for kidney transplant patients: safer CMV prevention on the horizon?
Disease control OngoingThis study is being done to compare the effectiveness of de novo Letermovir versus valganciclovir in preventing the development of cytomegalovirus viremia or symptomatic disease in African American kidney transplant recipients within the first year after transplantation. There a…
Phase: PHASE3 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to regrow hair in severe alopecia
Disease control CompletedThe primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Thousands to track omnipod 5 in daily life: will the smart pump deliver on its promise?
Disease control Recruiting nowThis is a decentralized observational clinical registry to collect real-world evidence related to the safety and effectiveness of the Omnipod 5 system in children and adults with Type 1 Diabetes.
Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Flavonoid fisetin aims to reverse vascular aging in seniors
Disease control OngoingThis is a pilot clinical trial to test the efficacy of intermittent treatment with the flavonoid compound fisetin for improving vascular endothelial function and reducing aortic stiffness in older adults. This trial will also determine the potential mechanisms by which fisetin ma…
Phase: PHASE1, PHASE2 • Sponsor: University of Colorado, Boulder • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Concrete floors could slash child infections in bangladesh
Prevention OngoingThis randomized trial in rural Bangladesh will measure whether installing concrete floors in households with soil floors reduces child enteric infection. The trial will randomize eligible households to receive concrete household floors or to no intervention and measure effects on…
Phase: NA • Sponsor: Stanford University • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Multiple fecal transplants may beat single dose for c. diff in colitis patients
Disease control Recruiting nowClostridioides difficile infection (CDI) is the most frequent cause of infectious diarrhea in hospitalized patients and is responsible for 20-30 % of antibiotic-associated diarrhea cases. Inflammatory bowel diseases (IBD) are associated with an higher prevalence, recurrence and s…
Phase: PHASE1, PHASE2 • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New combo targets Hard-to-Treat cancers with gene mutations
Disease control TerminatedThis phase II ComboMATCH treatment trial tests the usual treatment of chemotherapy (paclitaxel) plus ipatasertib in patients with solid tumor cancers that that cannot be removed by surgery (unresectable), has spread to nearby tissue or lymph nodes (locally advanced) or from where…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Wearable device aims to cut heart failure hospital stays
Disease control Recruiting nowThe primary purpose for this study is to support the hypothesis (pilot data) that the use of the Sensinel CPM system reduces the rate of HF-related events and the related healthcare cost. The study will also measure the impact on quality of care and patient satisfaction. In order…
Phase: NA • Sponsor: Analog Device, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a 2-Day therapy session help veterans with PTSD?
Symptom relief Recruiting nowThe goal of this clinical trial is to compare two different intensive formats of delivering cognitive-behavioral treatment for people with PTSD and anxiety disorders. The main questions it aims to answer are: * Is iTCBT delivered in individual and group formats more effective th…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Can a breast cancer drug reach brain tumors? new study aims to find out
Knowledge-focused Recruiting nowThe purpose of this study is to find out how much tratuzumab deruxtecan (T-DXd) can penetrate the tumor when injected into the body, and whether T-DXd may be an effective treatment for brain cancers that express the HER2 protein.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Weekly combo shot shows promise for diabetes control
Disease control CompletedThis study looks at how a new medicine insulin icodec helps in reducing blood sugar levels when given along with semaglutide in patients with type 2 diabetes. Participants will get the medicine insulin icodec once a week in the first part of the study (run-in period-26 weeks). Pa…
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Frozen embryo transfer: one extra day could boost success rates
Knowledge-focused TerminatedThe goal of this study is to compare the difference in clinical pregnancy, miscarriage and livebirth rate between day 6 euploid blastocyst transfer on the 6th and the 7th day of progesterone exposure in Hormonal Replacement Therapy (HRT) FET cycles. This prospective \& randomized…
Phase: PHASE1 • Sponsor: ART Fertility Clinics LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New hope for amyloidosis patients: Long-Term safety study of AT-02 underway
Disease control OngoingThis is a Phase 2 open-label extension study to evaluate the long-term safety, tolerability, and clinical activity of AT-02. AT-02 is an investigational medicinal product being developed to treat systemic amyloidosis.
Phase: PHASE2 • Sponsor: Attralus, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New blood test and camera could spot breast cancer earlier, reduce unnecessary biopsies
Diagnosis Recruiting nowThe goal of this research study is to evaluate the performance of two experimental tests, namely Liquid Biopsy and Positron Emission Mammography (PEM) in women at high risk of breast cancer. The plan for this study is to assess whether findings from the combination or each indivi…
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 12:24 UTC
-
New drug duo aims to shrink prostate tumors before surgery
Disease control CompletedA Study to Investigate the Biological Effects of Saruparib (AZD5305) Alone, Darolutamide Alone, and in Combination Given Prior to Radical Prostatectomy in Men with Newly Diagnosed Prostate Cancer (ASCERTAIN).
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Phone app aims to help kids sleep their way to a healthy weight
Prevention Recruiting nowThe overall objective of this application is to develop a mobile health platform for the pediatric care setting to promote longer sleep duration for childhood obesity prevention.
Phase: NA • Sponsor: Children's Hospital of Philadelphia • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
New drug shows promise for improving walking in adults with spinal muscular atrophy
Symptom relief CompletedThe purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3
Phase: PHASE2 • Sponsor: NMD Pharma A/S • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New depression drug shows promise in large trial
Symptom relief CompletedThis is a randomized, double blind, placebo controlled, multi-center study to evaluate the effects of NMRA-335140 (formerly BTRX 335140) on symptoms of depression in participants with Major Depressive Disorder (MDD). The study design consists of a Screening Period (up to 28 days)…
Phase: PHASE3 • Sponsor: Neumora Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control CompletedThe purpose of this trial is to test different doses of the trial medicine (LEO 138559) and see how well they work and how safe they are at treating moderate to severe atopic dermatitis in adults. There will be 4 different doses, that will also be compared to a placebo (a dummy m…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC